Alterity Therapeutics Stock (NASDAQ: ATHE) stock price, news, charts, stock research, profile.
You can purchase shares of Alterity Therapeutics (NASDAQ:ATHE) through any online brokerage.
Other companies in Alterity Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), CARISMA Therapeutics (NASDAQ:CARM), Nanoviricides (AMEX:NNVC), Bolt Biotherapeutics (NASDAQ:BOLT) and Palatin Techs (AMEX:PTN).
Alterity Therapeutics has a consensus price target of $6.25.
The stock price for Alterity Therapeutics (NASDAQ: ATHE) is $2.02 last updated December 19, 2024 at 5:04 PM EST.
There are no upcoming dividends for Alterity Therapeutics.
Alterity Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Alterity Therapeutics.
Alterity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.